Your session is about to expire
← Back to Search
Tirzepatide - Test for Healthy Subjects
Study Summary
This trial evaluates the effectiveness, safety and tolerability of tirzepatide. Participants will be monitored over 14 weeks, and side effects recorded.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Logistics
Participation is compensated
You will be compensated for participating in this trial.
Who is running the clinical trial?
Frequently Asked Questions
Has the FDA sanctioned Tirzepatide - Test?
"Limited clinical data exists surrounding the safety and efficacy profiles of Tirzepatide, so it recieved a score of 1."
Do individuals of a certain age qualify for this clinical experiment?
"This trial has distinct guidelines that only allow participants aged between 18 and 70 to take part. There are 54 studies for minors, while 372 are available for seniors."
What are the eligibility requirements for participation in this clinical research project?
"To partake in this medical experiment, subjects must be fit and between 18 to 70 years old. At the moment, 65 people are being enrolled for the trial."
Are there any available slots for participants in this research endeavor?
"According to clinicaltrials.gov, this research project is no longer recruiting members for participation; the trial was first posted on April 3rd 2023 and its most recent update was made on March 31st 2023. Although it is not actively seeking candidates now, there are 817 ongoing trials currently looking for participants."
Who else is applying?
What state do they live in?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Why did patients apply to this trial?
Share this study with friends
Copy Link
Messenger